Furthermore, Forschner et al. successfully used a combination of CDK4/6 and MEK inhibitors to treat a patient with NRAS-mutated metastatic melanoma resistant to immunotherapy [75]. The gene discussed is MAP2K7; the disease is metastatic melanoma.